Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › Marsh & McLennan Companies, Inc. (MMC) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Insurance Brokers
$229.33
+0.86 (0.38%)10 Quality Stocks Worth Considering Now
Researching Marsh & McLennan (MMC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MMC and similar high-potential opportunities.
Based on our analysis of 25 Wall Street analysts, MMC has a neutral consensus with a median price target of $236.00 (ranging from $189.21 to $276.00). The overall analyst rating is Buy (6.6/10). Currently trading at $229.33, the median forecast implies a 2.9% upside. This outlook is supported by 5 Buy, 12 Hold, and 3 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MMC.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Apr 21, 2025 | Keefe, Bruyette & Woods | Meyer Shields | Underperform | Maintains | $215.00 |
Apr 11, 2025 | Barclays | Alex Scott | Equal-Weight | Maintains | $249.00 |
Apr 11, 2025 | Jefferies | Yaron Kinar | Hold | Maintains | $244.00 |
Apr 10, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $232.00 |
Apr 9, 2025 | UBS | Brian Meredith | Buy | Maintains | $261.00 |
Apr 9, 2025 | Keefe, Bruyette & Woods | Meyer Shields | Underperform | Maintains | $220.00 |
Feb 6, 2025 | Raymond James | C. Gregory Peters | Outperform | Reiterates | $250.00 |
Feb 3, 2025 | Keefe, Bruyette & Woods | Meyer Shields | Underperform | Maintains | $210.00 |
Jan 31, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $223.00 |
Jan 10, 2025 | Keefe, Bruyette & Woods | Meyer Shields | Underperform | Maintains | $214.00 |
Jan 3, 2025 | JP Morgan | Jimmy Bhullar | Neutral | Maintains | $235.00 |
Dec 12, 2024 | RBC Capital | Scott Heleniak | Outperform | Upgrade | $250.00 |
Nov 25, 2024 | Evercore ISI Group | David Motemaden | Outperform | Reinstates | $242.00 |
Nov 21, 2024 | Barclays | Alex Scott | Equal-Weight | Maintains | $246.00 |
Oct 22, 2024 | UBS | Brian Meredith | Buy | Maintains | $259.00 |
Oct 22, 2024 | Keefe, Bruyette & Woods | Meyer Shields | Underperform | Maintains | $212.00 |
Oct 22, 2024 | BMO Capital | Michael Zaremski | Market Perform | Maintains | $228.00 |
Oct 18, 2024 | RBC Capital | Scott Heleniak | Sector Perform | Maintains | $242.00 |
Oct 18, 2024 | Roth MKM | Harry Fong | Neutral | Maintains | $230.00 |
Oct 10, 2024 | B of A Securities | Joshua Shanker | Neutral | Maintains | $250.00 |
The following stocks are similar to Marsh & McLennan based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Marsh & McLennan Companies, Inc. has a market capitalization of $111.76B with a P/E ratio of 27.8x. The company generates $25.05B in trailing twelve-month revenue with a 16.1% profit margin.
Revenue growth is +9.1% quarter-over-quarter, while maintaining an operating margin of +30.4% and return on equity of +30.5%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Global professional services firm specializing in risk management.
The company operates through two main segments: Risk and Insurance Services and Consulting. It earns revenue by providing risk management services, insurance brokerage, and consulting services across various industries. By optimizing clients' risk profiles and ensuring consistent growth, it creates value for a diverse clientele.
Founded in 1871 and headquartered in New York City, the company has a strong market position driven by its extensive expertise and global reach. Its subsidiaries, including Marsh, Guy Carpenter, Mercer, and Oliver Wyman, enhance its service offerings in risk assessment and strategic consulting.
Financial Services
Insurance Brokers
90,000
Mr. John Quinlan Doyle
United States
1987
MMC has maintained consistent cash flow generation for several years, supporting its disciplined capital distribution.
MMC has demonstrated consistent cash flow generation over several years, which supports its disciplined approach to capital distribution.
Consistent cash flow indicates financial stability and reliability, enhancing MMC's ability to sustain dividends and reinvest, which can attract investors looking for steady returns.
MMC's roll-up strategy, including the McGriff acquisition, enhances scale and recurring revenue in insurance brokerage. High returns on equity and reasonable valuation suggest long-term investment potential.
MMC's strategic acquisitions enhance scale and profitability, leading to strong returns and competitive advantages, while reasonable valuations suggest potential for long-term gains.
Marsh McLennan (NYSE: MMC) announced that stockholders elected all 11 director nominees for one-year terms at its 2025 Annual Meeting.
The election of the entire slate of directors at Marsh McLennan supports continuity in leadership, which can enhance stability and confidence in the company's strategic direction for investors.
Mercer and the National Commission on Climate and Workforce Health launched the Climate Health Cost Forecaster, a tool for employers to estimate climate-related healthcare costs impacting their workforce.
The launch of the Climate Health Cost Forecaster by Mercer signals a growing focus on climate-related risks, potentially affecting employer costs, workforce health, and overall market stability.
Oliver Wyman has launched a Labor Cost per Vehicle analysis, addressing labor costs' impact on automaker profitability amid economic challenges and geopolitical tensions.
The Labor Cost per Vehicle analysis impacts automaker profitability amid economic and geopolitical challenges, influencing investment decisions in the automotive sector.
Mercer, part of Marsh McLennan (NYSE: MMC), has completed its acquisition of SECOR Asset Management, enhancing its investment and portfolio solutions for institutional investors. Terms were not disclosed.
Mercer's acquisition of SECOR Asset Management enhances its investment capabilities, potentially increasing its competitiveness and revenue, which could positively impact Marsh McLennan's stock performance.
Based on our analysis of 25 Wall Street analysts, Marsh & McLennan Companies, Inc. (MMC) has a median price target of $236.00. The highest price target is $276.00 and the lowest is $189.21.
According to current analyst ratings, MMC has 5 Buy ratings, 12 Hold ratings, and 3 Sell ratings. The stock is currently trading at $229.33. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict MMC stock could reach $236.00 in the next 12 months. This represents a 2.9% increase from the current price of $229.33. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates through two main segments: Risk and Insurance Services and Consulting. It earns revenue by providing risk management services, insurance brokerage, and consulting services across various industries. By optimizing clients' risk profiles and ensuring consistent growth, it creates value for a diverse clientele.
The highest price target for MMC is $276.00 from at , which represents a 20.4% increase from the current price of $229.33.
The lowest price target for MMC is $189.21 from at , which represents a -17.5% decrease from the current price of $229.33.
The overall analyst consensus for MMC is neutral. Out of 25 Wall Street analysts, 5 rate it as Buy, 12 as Hold, and 3 as Sell, with a median price target of $236.00.
Stock price projections, including those for Marsh & McLennan Companies, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.